Breaking News
Get 50% Off 0
Top 10 Stocks Best Positioned to Break Out This Earnings Season
See the List
Close

Jilin Aodong Pharmaceutical Group Co Ltd (000623)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
19.08 -0.21    -1.09%
08:44:59 - Closed. Currency in CNY
Type:  Equity
Market:  China
ISIN:  CNE000000719 
  • Volume: 17,448,363
  • Bid/Ask: 19.08 / 19.08
  • Day's Range: 19.04 - 19.30
Aodong A 19.08 -0.21 -1.09%

Jilin Aodong Pharmaceutical Group Co Ltd Company Profile

 
Get an in-depth profile of Jilin Aodong Pharmaceutical Group Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

5646

Equity Type

ORD

Jilin Aodong Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China. The company provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in the highway construction and toll collection businesses; animal husbandry activities; manufacture of specialty chemicals; production and supply of heat and water; wholesale, retail, and distribution of medicines; production and sale of packaging materials; and information consulting and advertising design and production activities. In addition, the company offers pharmaceutical excipients and packaging materials; produces and sells enzyme stock solutions; ginseng and antler products; sells health care products; and processes edible agricultural products, etc. Further, it provides products in cardiovascular; women and children medication; liver, gallbladder, and stomach; antipyretic and analgesic; rheumatic bone disease; antibacterial and anti-inflammatory; relieve cough and reduce phlegm; and urinary medication therapeutic areas, as well as medical devices, health foods, and others. Jilin Aodong Pharmaceutical Group Co., Ltd. was founded in 1957 and is headquartered in Dunhua, China.

Contact Information

Address 2158 Aodong Street
Dunhua, 133700
China
Phone 86 43 3623 8973
Fax 86 43 3623 8973

Top Executives

Name Age Since Title
Shuqin Guo 57 - Vice Chairman & GM
Xiulin Li 70 1993 Chairman
Kai Yang 46 2017 Deputy GM & Director
Yongfeng Chen 55 2017 Chief Supervisor
Dalong Zhao 50 2020 Director
Gang Xiu 58 2017 Member of Supervisory Board
Shuyuan Zhang 52 2017 CFO, Financial Director, Deputy GM & Director
Yuju Sun 52 2008 Member of Supervisory Board
Mingjing Zhang 42 2018 Employees Representative Member of the Supervisory Board
Weiwei Xiao 44 2020 Independent Director
Anning Li 38 2022 Employees Representative Member of the Supervisory Board
Peng Li 42 2020 Independent Director
Biming Liang 46 2023 Independent Director
Zhen Yu Wang 43 2017 Deputy GM, Secretary of the Board & Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

000623 Comments

Write your thoughts about Jilin Aodong Pharmaceutical Group Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email